Skip to main content

Table 3 Number of immunoreactive linear epitopes identified in human EBOV (1:12,800) and BOMV (1:800) reactive serum samples compared to a negative human serum sample by gene and overall for all six ebolaviruses and Marburg virus

From: Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak

  EBOV Presumptive Positive Patient BOMV Presumptive Positive Patient Negative Human
Peptide NP VP35 VP40 GP VP30 VP24 L Tot NP VP35 VP40 GP VP30 VP24 L Tot NP VP35 VP40 GP VP30 VP24 L Tot
EBOV 2   1 3    3 9 9   4 10 4   16 43         
BOMV 4    2 1   4 11 10 6 3 10 3 2 18 52   1   1    1 3
SUDV     1   1 2 4 8   1 12 5   16 42     1    1 2
BDBV 2    3 1   4 10 7   1 10 2   15 35         
TAFV 3     1   2 6 9   3 10 2   18 42         
REST 3    2    4 9 9    11 3   18 41 2    3     5
MARV 2       1 3 9   4 13 3   22 51     2 1    3